Abstract
Sesquiterpene lactones (SLs) are biologically active compounds found in various medicinal plants. Although the compounds are reported to possess numerous biological activities, but the most important is their immunoregulatory role in inflammatory cells. This is because 1) over-activation of inflammatory cells secretes a large amount of different pro-inflammatory mediators such as cytokines, nitric oxide (NO) and prostaglandin (PG)E2 and 2) SLs can modulate these phenomena effectively through inhibiting the activation pathway of nuclear factor (NF)-κB via the reactivity of some functional groups in SLs such as α-methylene-γ- lactone. This review, therefore, discusses in detail the molecular mechanism and structural features of SLs in blocking NF-κB activation with a general introduction of NF-κB and proposes the possibility that SLs can be developed pharmaceutically useful drugs against NF-κB-mediated diseases and that they can be chemically modified to improve their anti-NF-κB efficacy.
Keywords: Sesquiterpene lactones, NF-κB, I-κB, cytokines, inflammatory mediators, structure-activity relationship study
Current Enzyme Inhibition
Title: Sesquiterpene Lactones as a Potent Class of NF-κB Activation Inhibitors
Volume: 2 Issue: 4
Author(s): Jae Youl Cho
Affiliation:
Keywords: Sesquiterpene lactones, NF-κB, I-κB, cytokines, inflammatory mediators, structure-activity relationship study
Abstract: Sesquiterpene lactones (SLs) are biologically active compounds found in various medicinal plants. Although the compounds are reported to possess numerous biological activities, but the most important is their immunoregulatory role in inflammatory cells. This is because 1) over-activation of inflammatory cells secretes a large amount of different pro-inflammatory mediators such as cytokines, nitric oxide (NO) and prostaglandin (PG)E2 and 2) SLs can modulate these phenomena effectively through inhibiting the activation pathway of nuclear factor (NF)-κB via the reactivity of some functional groups in SLs such as α-methylene-γ- lactone. This review, therefore, discusses in detail the molecular mechanism and structural features of SLs in blocking NF-κB activation with a general introduction of NF-κB and proposes the possibility that SLs can be developed pharmaceutically useful drugs against NF-κB-mediated diseases and that they can be chemically modified to improve their anti-NF-κB efficacy.
Export Options
About this article
Cite this article as:
Youl Cho Jae, Sesquiterpene Lactones as a Potent Class of NF-κB Activation Inhibitors, Current Enzyme Inhibition 2006; 2 (4) . https://dx.doi.org/10.2174/157340806778699299
DOI https://dx.doi.org/10.2174/157340806778699299 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cytokine-Induced Depression: Current Status and Novel Targets for Depression Therapy
CNS & Neurological Disorders - Drug Targets Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry Apoptotic Signaling in Pancreatic Cancer – Therapeutic Application (Supplemental Data)
Current Cancer Therapy Reviews Phytochemical Characterization of Prickly Pear (Opuntia spp.) and of its Nutritional and Functional Properties: A Review
Current Nutrition & Food Science A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems
Pharmaceutical Nanotechnology Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge
Current Stem Cell Research & Therapy Current Role of Proteomics in Pancreatic Cancer Biomarkers Research
Current Proteomics Controversies in Glaucoma: Current Medical Treatment and Drug Development
Current Pharmaceutical Design An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect
Current Pharmaceutical Biotechnology The Cancer Related Thrombotic Tendency in Sepsis
Current Drug Targets Perivascular Adipose Tissue Oxidative Stress on the Pathophysiology of Cardiometabolic Diseases
Current Hypertension Reviews Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications
Current Medicinal Chemistry Editorial (Thematic Issue: Lipidic Nano-carrier Delivery of “Big” Molecules)
Current Pharmaceutical Biotechnology Cephalosporin Conjugated Sulfonamides: Synthesis, Characterization and Anticancer Activities
Letters in Drug Design & Discovery Angiotensin II: Role in Skeletal Muscle Atrophy
Current Protein & Peptide Science Respiratory Muscle Dysfunction in COPD: From Muscle to Cell
Current Drug Targets Subject Index To Volume 7
Current Drug Targets Potential Novel Anxiolytic Drugs
Current Pharmaceutical Design Modulating Mesenchymal Stromal Cell Function with Cholesterol Synthesis Inhibitors
Current Medicinal Chemistry SHP-2 Regulates Growth Factor Dependent Vascular Signalling and Function
Mini-Reviews in Medicinal Chemistry